Ophthalmic high-level disinfectant now approved for immediate sale in the US With c.16 million ophthalmic procedures taking place every year in North America, the Board believes that FDA clearance has ...
BOSTON - Tristel plc (AIM:TSTL) exhibited at the Association for Professionals in Infection Control and Epidemiology (APIC) 2025 conference, where it launched Tristel OPH, a high-level disinfectant ...
Earnings call Tristel reported H1 revenue up 14% YoY to GBP 25.6 million, with adjusted EBITDA margin at 29% and double-digit growth in key European markets. Management remains confident in meeting ...
(Sharecast News) - Tristel announced on Monday that it has received FDA clearance to begin immediate sales of its ophthalmic disinfectant foam, Tristel OPH, in the United States. The AIM-traded firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results